Morningstar - Comcast Corporation Class A (CMCSA) Comcast Announces MVNO Service Aimed at Existing Customer Base; Maintain $33 FVE

Report

Morningstar

Neil Macker

EUR 98.48 For Business Accounts Only

Comcast Announces MVNO Service Aimed at Existing Customer Base; Maintain $33 FVE

Comcast held an analyst event to introduce its widely anticipated Mobile Virtual Network Operator, or MVNO, service that will be branded as Xfinity Mobile and hosted by Verizon. While the company did not announce a specific date, we expect the service will launch before the end of the second quarter. The service will be aimed at the companyâ€™s current customer base of 25 million home Internet subscribers, and management expects the product to help increase the uptake of the firmâ€™s bundled service...

06/04/2017 14 EN

Underlying

Comcast Corporation Class A

Comcast is a media and technology company. The company's segments are: Cable Communications, which provides internet, video, voice, and security and automation services in the United States individually and as bundled services at a discounted rate over its cable distribution system to residential and business customers; NBCUniversal, which includes a portfolio of national cable networks that provide a variety of entertainment, news and information, and sports content, regional sports and news networks, international cable networks, and cable television studio production operations; and Sky, which owns a portfolio of pay television channels that provide entertainment, news, sports and movies.

See profile

US20030N1019 NASDAQ Stock Market United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Neil Macker

Other Reports on these Companies

New Street Research

Autumn for Broadband 3Q25 – FWA ascendant, Cable struggling

We share here, in our latest Autumn for Broadband report, a quick update on broadband industry trends based on reported company results so far. Industry net adds have improved substantially from a year ago but remain below last year’s when adjusted for ACP impact. Net adds for the quarter were higher than the pre-pandemic norm but trailing twelve-month net adds remain below pre-pandemic levels. We take a deep-dive into FWA’s continued strong momentum by carrier.

EUR 8629.00

November 5, 2025 November 5, 2025 1 EN

New Street Research

Charter: Subscribers and EBITDA growth heading lower

There is a lot that’s common between Charter and Comcast, and yet there is a lot that’s different about the two companies. Both are operating in an environment where broadband subscriber growth remains a distant dream. Where the two companies differ is expectation around EBITDA growth. While both companies expect EBITDA to decline in 4Q25, Charter expects to grow EBITDA in 2026 unlike Comcast which expects EBITDA to decline in 2026. We also think Charter has higher pricing power than Comcast.

October 31, 2025 October 31, 2025 1 EN

New Street Research

Comcast: Tough next few quarters

Comcast is making the right moves in trying to fix their Cable business. These moves will take time to deliver tangible results. For now, we expect some near-term pain. Broadband ARPU growth will remain challenged as the company forgoes price hikes in early 2026. ARPU will also remain pressured due to the continued migration of customers to new pricing. ARPU growth is the biggest driver of EBITDA growth. With ARPU growth remaining challenged, we expect EBITDA declines of mid-single digits over the next three quarters before things start to improve.

October 30, 2025 October 30, 2025 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Joe Gemino

Joe Gemino

Sasol Provides Full-Year Production Update

No-moat Sasol provided an update on its full-year fiscal 2019 production metrics that included relatively stable liquids production. For the full year ended June 30, Sasol produced 1,470 thousand barrels of crude oil and condensate a day compared with 1,469 mboe/d in the year-ago period. However, declines continued with the companyâ€™s natural gas production, down 4% to 130.3 billion cubic feet compared with the period ended June 30, 2018. Sasol also reported flat refined products of 31.4 mmboe/d ...

EUR 100.00

July 25, 2019 July 25, 2019 12 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Comcast Announces MVNO Service Aimed at Existing Customer Base; Maintain $33 FVE

Autumn for Broadband 3Q25 – FWA ascendant, Cable struggling

Charter: Subscribers and EBITDA growth heading lower

Comcast: Tough next few quarters

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Sasol Provides Full-Year Production Update

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe